1. Home
  2. TCRX vs YIBO Comparison

TCRX vs YIBO Comparison

Compare TCRX & YIBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRX
  • YIBO
  • Stock Information
  • Founded
  • TCRX 2018
  • YIBO 2011
  • Country
  • TCRX United States
  • YIBO China
  • Employees
  • TCRX N/A
  • YIBO N/A
  • Industry
  • TCRX Biotechnology: Pharmaceutical Preparations
  • YIBO
  • Sector
  • TCRX Health Care
  • YIBO
  • Exchange
  • TCRX Nasdaq
  • YIBO NYSE
  • Market Cap
  • TCRX 170.1M
  • YIBO 185.8M
  • IPO Year
  • TCRX 2021
  • YIBO 2024
  • Fundamental
  • Price
  • TCRX $2.40
  • YIBO $3.22
  • Analyst Decision
  • TCRX Strong Buy
  • YIBO
  • Analyst Count
  • TCRX 5
  • YIBO 0
  • Target Price
  • TCRX $11.40
  • YIBO N/A
  • AVG Volume (30 Days)
  • TCRX 544.4K
  • YIBO 9.6K
  • Earning Date
  • TCRX 03-05-2025
  • YIBO 09-13-2024
  • Dividend Yield
  • TCRX N/A
  • YIBO N/A
  • EPS Growth
  • TCRX N/A
  • YIBO N/A
  • EPS
  • TCRX N/A
  • YIBO 0.17
  • Revenue
  • TCRX $9,362,000.00
  • YIBO $153,281,000.00
  • Revenue This Year
  • TCRX N/A
  • YIBO N/A
  • Revenue Next Year
  • TCRX $5.14
  • YIBO N/A
  • P/E Ratio
  • TCRX N/A
  • YIBO $18.81
  • Revenue Growth
  • TCRX N/A
  • YIBO 5.90
  • 52 Week Low
  • TCRX $2.38
  • YIBO $1.80
  • 52 Week High
  • TCRX $9.69
  • YIBO $7.83
  • Technical
  • Relative Strength Index (RSI)
  • TCRX 25.27
  • YIBO 46.39
  • Support Level
  • TCRX $2.60
  • YIBO $2.79
  • Resistance Level
  • TCRX $2.85
  • YIBO $3.63
  • Average True Range (ATR)
  • TCRX 0.17
  • YIBO 0.34
  • MACD
  • TCRX 0.00
  • YIBO -0.02
  • Stochastic Oscillator
  • TCRX 2.41
  • YIBO 40.76

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About YIBO PLANET IMAGE INTERNATIONAL LIMITED

Planet Image International Ltd is engaged in manufacturing and selling compatible toner cartridges. It develops and manufactures toner cartridges that are compatible with, and can be used in, a wide range of commonly available models of laser printers from different manufacturers, or compatible toner cartridges, on a white-label or third-party brand basis or under its self-owned brands. The company also sells its branded products through online sales channels under three brands, TrueImage, CoolToner, and AZtech. The company operates in North America, Europe, and Other countries.

Share on Social Networks: